Frequently asked questions

No, due to the blood-brain barrier, tumour cells cannot enter the bloodstream. This means that we cannot obtain and isolate any tumour cells from the blood sample.

Yes, patients with lymphoma or leukaemia can use an RGCC test to measure the number of circulating tumour cells (CTC) they have.

The most comprehensive test is the “Onconomics Plus” test. This provides information on the sensitivity or resistance of the patient’s tumour cells to certain cancer drugs and shows options for targeted therapy or an alternative treatment method with organic substances. The test also contains information about the development of the tumour and its potential by identifying epigenetic tumour markers relevant for the therapy, which are crucial for the correct therapeutic approach.

Online consultations will give you the opportunity to speak to any member of the RGCC Network at a time and place that is convenient to you. You will be able to choose from a shortlist of clinicians who best suit your needs.

Your chosen clinician will be in touch to make the arrangements and choose the most convenient method.

Our global team of cancer experts are on hand to provide support and advice to both patients and fellow RGCC clinicians. You can filter your clinician search by geographic location, areas of speciality, RGCC test expertise and more, and find detailed information within the clinician profiles. This means you can select the right clinicians for your individual needs.

RGCC has developed a range of tests to discover, analyse and screen cancer cells. We currently offer 11 tests that can detect potential early signs of cancer, monitor existing diagnosed cancers and provide personalised guidance on the most effective combination of cancer treatments and therapies, including complementary therapies.

If you have any symptoms of cancer, you should speak to a qualified medical professional urgently. You can book a consultation with an RGCC Network clinician by sending us a message via our website. Alternatively, you can download and print this letter and take it along with you to your appointment.

RGCC tests are designed to provide medical information and advice for clinicians. The information contained in the results needs to be interpreted by the clinician in charge of your care. If you are a patient interested in learning more about RGCC’s range of tests, you can find your nearest RGCC clinician by sending us a message via our website. Alternatively, you can download and print this letter and take it along with you to your appointment.

RGCC tests are only available to the RGCC Network of healthcare professionals. We are always looking to connect with individuals and organisations who share our values. If you are a health professional interested in learning more about the RGCC Network, please contact your local branch office.

Once you have ordered your RGCC test, you will need to provide us with a sample of blood. We will provide all shipping instructions to ensure the sample arrives in perfect condition. The sample is processed at one of our world-leading laboratories. Once the test is completed, we provide you with a detailed breakdown of what we have found. We recommend that you and your patient discuss your results and work together to develop a personalised treatment plan based on our findings. You can learn more about the RGCC test process by visiting the RGCC test pages or downloading our patient information leaflet.

RGCC’s tests are at the cutting-edge of medical science and are not currently offered by healthcare providers. Health providers, such as the NHS, are trialling genetic testing to diagnose and treat cancer. In the future, it is likely that genetic testing will be offered by all healthcare providers. At RGCC, we believe that everyone should be able to experience the benefits of personalised medicine. Our range of genetic tests is currently available in 23 countries through the RGCC Network of healthcare professionals. To find your nearest RGCC registered clinician, send us a message via our website.